Influence of nasal highflow-therapy on oxygenation index compared with lowflowoxygen-therapy in patients with comunitiy aquired pneumonia on peripheral ward

Not Applicable

Recruiting

Conditions: Community acquired pneumonia
Viral pneumonia, not elsewhere classified
J12

Registration Number: DRKS00023528

Lead Sponsor: niversitätsklinikum FrankfurtMedizinische Klinik 1Pneumologie/Allergologie

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 34

Inclusion Criteria

age >18Jahre
- diagnosis of community aquired pneumonia (conilidation chest-X-ray or CT-scan)
- mild to moderate disturbance of oxygenation (oxigenation index 100-300)

Exclusion Criteria

- oxygenation index < 100
- COVID19-pneumonia
- pregnance
- age < 18
- missing of patients consent

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
oxygenation index d 3 after study enrollment

Secondary Outcome Measures

Name	Time	Method
- sociodemographic data<br>o gender<br>o year of birth<br>- Patient data <br>o height<br>o weight<br>o BMI<br>- risc factors<br>o CRB-65-Score<br>o Q-SOFA-Score <br>o smoking<br>o dysphagia<br>- pulmonary disease<br>o emphysema<br>o COPD<br>o Asthma<br>o ILD<br>- immunosuppression<br>o drug induced iimmunosuppression<br>o habituell immunosuppression<br>- lungfunction<br>o FVC (absolute/% normal)<br>o FEV1/VC<br>o FEV1 (absolute/% normal)<br><br><br>- symptomas<br>o dyspnoea Borgscala (1-10)<br>--time of recruiting, day 1,2 3 and before discharge<br>- pO2/pCO2, pH <br>-- at time of admission, day 1,2,3 and before discharge, furthermore 1-2 h after changing of therapy<br><br>- therapy<br>o Highflow:<br>? rate (l/min)<br>? fiO2<br>? temperature (°C)<br>? utilisation (h)<br>o lowflow<br>? application form<br>? l/min<br>- hospitilisation data<br>o ICU<br>o time of Ventilation<br>o length of stay<br>o mortality<br>- microbiologic data<br><br>concomitant diseases